Picture of Richter Gedeon Vegyeszeti Gyar Nyrt logo

RICHTER Richter Gedeon Vegyeszeti Gyar Nyrt News Story

0.000.00%
hu flag iconLast trade - 00:00
HealthcareConservativeLarge CapSuper Stock

Brief: Hungary's Richter CEO reiterates 2024 guidance

Nov 12 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
 GDRB.BU  CEO Gabor Orban:
    * 2024 GUIDANCE REITERATED
    * PHARMA REVENUES AND CLEAN EBIT EXPECTED TO COME IN CLOSER
TO THE
LOWER END OF THE UNCHANGED GUIDANCE RANGE
    * EXCHANGE RANGE MOVEMENTS PROVIDED TAILWIND
    * WE SAW DOUBLE-DIGIT GROWTH IN ALL SEGMENTS IN Q3
    * OPERATING EXPENSES WERE HIGHER THAN EXPECTED DUE TO
ACQUISITIONS
    * LOWER VRYLAR INCOME WAS OFFSET BY MILESTONE PAYMENT FROM
ABBVIE
AFTER NEW RESEARCH AND DEVELOPMENT COLLABORATION SIGNED IN
OCTOBER

Source text: [https://bet.hu/newkibdata/129151822/PresentationQ32024.pdf
]
Further company coverage:  GDRB.BU 

 (Reporting by Anita Komuves)
 ((KOMUVES.Anita@thomsonreuters.com;))

Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt

See all news